TheHerdLocker.com Skip to content…
  • Recent
  • Popular

Highest ranked #oncology content from the past 7 Days

The algorithm reads every tweet and filters out links to stuff it has seen before: ignoring retweets, duplicate posts, shortened URLs pointing to the same content and so on. It notes who shared things first and keeps score by how many times it sees the link again.

Remember to check out the recent reports, showing the latest filtered tweets as fast as we can process them.

7 days 30 days 6 months+ Free Reports by Mail
    Previous1..45678910..183Next

Quick Navigation tip

Sorry to hit you with a mildly alarming red box, but in a report covering 1829 #oncology tweets you seem to have started your session a few pages in. An old bookmark or an obscure search engine link, perhaps.

In any case, you might be better starting at the begining:


Content in the order it arrived, most recent first

Content ranked in realtime, most shared first
First Shared by Shares Link What they said in the Tweet Date
@APCCardio 2 https://www.apccardiovascular.co.uk/covid-update/


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Our team are still on hand to support you and your hospitals #hereforyou #cardiology #cardiacsurgery #oncology #radiationprotection #noninvasivemonitoring #hemodynamics #interventional https://apccardiovascular.co.uk/covid-update/ https://t.co/m5xZPhBVIk
2021-01-21 09:32:46 UTC
REPORT IF NOT RELEVANT
@SmretiV 2 https://peerj.com/articles/10599/


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Our article has been published today in @thePeerJ https://peerj.com/articles/10599 #Epidemiology #InfectiousDiseases #Oncology
2021-01-21 11:42:14 UTC
REPORT IF NOT RELEVANT
@TRCIncorporated 2 https://www.sciencedaily.com/releases/2021/01/210112160207.htm


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Scientists from @CCI_UoS have gained new insight into activating the #ImmuneSystem to fight #cancer 👏 The study identifies how to modify antibodies and where to target them to trigger a more effective immune response. Read on in @ScienceDaily: https://okt.to/Dc8p6o #Oncology https://t.co/DWhPy2JS1Z
2021-01-21 14:05:39 UTC
REPORT IF NOT RELEVANT
@CancerTherAdvsr 2 https://www.cancertherapyadvisor.com/home/cancer-topics/lung-cancer/elderly-lung-cancer-nsclc-chemo-radiation-longer-survival/


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Combined modalities improve survival in elderly patients with stage III inoperable NSCLC. http://ow.ly/KP7550Desz1 #cancer #oncology
2021-01-21 14:08:50 UTC
REPORT IF NOT RELEVANT
@jmirpub 2 https://cancer.jmir.org/2021/1/e18396/


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
New in JMIR Cancer: Cardiovascular Assessment Tool for Breast #cancer Survivors and #oncology Providers: Usability #study http://dlvr.it/Rr2sCr
2021-01-21 14:10:05 UTC
REPORT IF NOT RELEVANT
@ASCOPost 2 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/milind-javle-on-cholangiocarcinoma-treatment-with-infigratinib/


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Milind M. Javle, MD, on #Cholangiocarcinoma: Treatment With Infigratinib https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/milind-javle-on-cholangiocarcinoma-treatment-with-infigratinib/ #GI21 #oncology #cancer @MDAndersonNews https://t.co/45mygH6fTK
2021-01-21 14:42:00 UTC
REPORT IF NOT RELEVANT
@OncoPublisher 2 https://medicalxpress.com/news/2021-01-vaccine-long-lasting-anti-tumor-response-patients.html


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Vaccine produces long-lasting anti-tumor response in patients with melanoma #Oncology #MedTwitter #MedEd https://medicalxpress.com/news/2021-01-vaccine-long-lasting-anti-tumor-response-patients.html
2021-01-21 16:11:47 UTC
REPORT IF NOT RELEVANT
@OncoPublisher 2 https://medicalxpress.com/news/2021-01-pre-surgery-chemotherapy-early-stage-pancreatic.html


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Pre-surgery chemotherapy is possible for early stage pancreatic cancer patients #Oncology #MedTwitter #MedEd https://medicalxpress.com/news/2021-01-pre-surgery-chemotherapy-early-stage-pancreatic.html
2021-01-21 16:11:50 UTC
REPORT IF NOT RELEVANT
@OncoPublisher 2 https://www.fiercebiotech.com/research/veruas-touts-novel-breast-cancer-treatment-strategy-as-drug-nears-phase-3


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Veru touts novel breast cancer treatment strategy as drug nears phase 3 #Oncology #MedTwitter #MedEd https://www.fiercebiotech.com/research/veruas-touts-novel-breast-cancer-treatment-strategy-as-drug-nears-phase-3
2021-01-21 17:45:41 UTC
REPORT IF NOT RELEVANT
@OncoPublisher 2 https://medicalxpress.com/news/2021-01-crispr-technology-team-tracks-lineage.html


Share the link yourself with
Tweet this LinkedIn Post to FB Post via Buffer
Using CRISPR technology, team tracks lineage of individual cancer cells as they proliferate and metastasize in real time #Oncology #MedTwitter #MedEd https://medicalxpress.com/news/2021-01-crispr-technology-team-tracks-lineage.html
2021-01-21 19:10:07 UTC
REPORT IF NOT RELEVANT
  • @APCCardio
    2 shares
    • ...was first to share https://www.apccardiovascular.co.uk/covid-update/ in this tweet:
    • Our team are still on hand to support you and your hospitals #hereforyou #cardiology #cardiacsurgery #oncology #radiationprotection #noninvasivemonitoring #hemodynamics #interventional https://apccardiovascular.co.uk/covid-update/ https://t.co/m5xZPhBVIk

      2021-01-21 09:32:46 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @SmretiV
    2 shares
    • ...was first to share https://peerj.com/articles/10599/ in this tweet:
    • Our article has been published today in @thePeerJ https://peerj.com/articles/10599 #Epidemiology #InfectiousDiseases #Oncology

      2021-01-21 11:42:14 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @TRCIncorporated
    2 shares
    • ...was first to share https://www.sciencedaily.com/releases/2021/01/210112160207.htm in this tweet:
    • Scientists from @CCI_UoS have gained new insight into activating the #ImmuneSystem to fight #cancer 👏 The study identifies how to modify antibodies and where to target them to trigger a more effective immune response. Read on in @ScienceDaily: https://okt.to/Dc8p6o #Oncology https://t.co/DWhPy2JS1Z

      2021-01-21 14:05:39 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @CancerTherAdvsr
    2 shares
    • ...was first to share https://www.cancertherapyadvisor.com/home/cancer-topics/lung-cancer/elderly-lung-cancer-nsclc-chemo-radiation-longer-survival/ in this tweet:
    • Combined modalities improve survival in elderly patients with stage III inoperable NSCLC. http://ow.ly/KP7550Desz1 #cancer #oncology

      2021-01-21 14:08:50 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @jmirpub
    2 shares
    • ...was first to share https://cancer.jmir.org/2021/1/e18396/ in this tweet:
    • New in JMIR Cancer: Cardiovascular Assessment Tool for Breast #cancer Survivors and #oncology Providers: Usability #study http://dlvr.it/Rr2sCr

      2021-01-21 14:10:05 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @ASCOPost
    2 shares
    • ...was first to share https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/milind-javle-on-cholangiocarcinoma-treatment-with-infigratinib/ in this tweet:
    • Milind M. Javle, MD, on #Cholangiocarcinoma: Treatment With Infigratinib https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/milind-javle-on-cholangiocarcinoma-treatment-with-infigratinib/ #GI21 #oncology #cancer @MDAndersonNews https://t.co/45mygH6fTK

      2021-01-21 14:42:00 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @OncoPublisher
    2 shares
    • ...was first to share https://medicalxpress.com/news/2021-01-vaccine-long-lasting-anti-tumor-response-patients.html in this tweet:
    • Vaccine produces long-lasting anti-tumor response in patients with melanoma #Oncology #MedTwitter #MedEd https://medicalxpress.com/news/2021-01-vaccine-long-lasting-anti-tumor-response-patients.html

      2021-01-21 16:11:47 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @OncoPublisher
    2 shares
    • ...was first to share https://medicalxpress.com/news/2021-01-pre-surgery-chemotherapy-early-stage-pancreatic.html in this tweet:
    • Pre-surgery chemotherapy is possible for early stage pancreatic cancer patients #Oncology #MedTwitter #MedEd https://medicalxpress.com/news/2021-01-pre-surgery-chemotherapy-early-stage-pancreatic.html

      2021-01-21 16:11:50 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @OncoPublisher
    2 shares
    • ...was first to share https://www.fiercebiotech.com/research/veruas-touts-novel-breast-cancer-treatment-strategy-as-drug-nears-phase-3 in this tweet:
    • Veru touts novel breast cancer treatment strategy as drug nears phase 3 #Oncology #MedTwitter #MedEd https://www.fiercebiotech.com/research/veruas-touts-novel-breast-cancer-treatment-strategy-as-drug-nears-phase-3

      2021-01-21 17:45:41 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
  • @OncoPublisher
    2 shares
    • ...was first to share https://medicalxpress.com/news/2021-01-crispr-technology-team-tracks-lineage.html in this tweet:
    • Using CRISPR technology, team tracks lineage of individual cancer cells as they proliferate and metastasize in real time #Oncology #MedTwitter #MedEd https://medicalxpress.com/news/2021-01-crispr-technology-team-tracks-lineage.html

      2021-01-21 19:10:07 UTC

    •  Share the link yourself with Tweet this LinkedIn Post to FB Post via Buffer
    Previous1..45678910..183Next

Go on -buy me a coffee  Go on - buy me a coffee
About   Credits   Terms of Use   Privacy   Free Weekly Reports   

© The Herd Locker 2016-2020. Bugs, questions or suggestions? Want to track a new hashtag? Just ask.

Loading…